[1]Synthesis(Germany),2016,vol.48,#1,p.131-135
[1]JournalofMedicinalChemistry,2004,vol.47,#19,p.4645-4648
[1]JournalofMedicinalChemistry,2012,vol.55,#11,p.5270-5290
[1]JournalofMedicinalChemistry,2004,vol.47,#19,p.4645-4648
[1]JournalofMedicinalChemistry,2004,vol.47,#19,p.4645-4648
[1]JournalofMedicinalChemistry,2004,vol.47,p.4645-4648
[1]JournalofMedicinalChemistry,2004,vol.47,p.4645-4648
[1]JournalofMedicinalChemistry,2004,vol.47,p.4645-4648
[1]JournalofMedicinalChemistry,2004,vol.47,p.4645-4648
[1]JournalofMedicinalChemistry,2012,vol.55,p.5270-5290
Title: Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
Journal: Journal of medicinal chemistry 20120614